We use cookies to improve our service for you. You can find more information in our data protection declaration.
Joe Biden and Kamala Harris have been sworn in during a ceremony with no public in attendance amid security and pandemic concerns. Donald Trump is the first modern president to skip the event. Follow DW for the latest. Go to article
As a new president takes the White House, EU observers are speculating about what it will mean for trans-Atlantic ties.
The US is in a state of crisis, both economically and culturally. Joe Biden has promised to restore humanity to the job.
What plans does the incoming US president have for relationships with the region?
Germans are pinning high hopes on the Joe Biden presidency. But how realistic is all the talk of a new beginning for the trans-Atlantic partnership?
Officials say 60% of Africa's 1.3 billion people will need vaccinates in order to achieve continentwide herd immunity.
A new study found that antibodies in patients vaccinated against COVID-19 were able to neutralize a version of the new variant. Researchers tested 10 mutations of the B117 variant, which was first identified in the UK.
Angela Merkel and Germany's 16 state premiers decided to keep the lockdown in place until at least mid-February. The new, tougher measures would also see people wearing filter masks in shops and on public transport.
Cairo and Doha have exchanged pledges to end their three-year rift and resume ties, according to Egypt's Foreign Ministry. Several allies of Saudi Arabia are in the process of reestablishing relations with Qatar.
A residential building has been seriously damaged by an explosion in Madrid. At least two people died in the blast, apparently caused by a gas leak.
Kremlin critic Alexei Navalny's team has released a report about a sprawling, opulent Black Sea palace allegedly owned by Russian President Vladimir Putin. The video was posted less than two days after Navalny's arrest.
Germany will prohibit the mass slaughter of day-old male chicks, according to a draft bill signed by the Cabinet. Critics say, however, that the new measure isn't far-reaching enough to protect animal welfare.
The British lawyer, David Perry, stepped down as lead prosecutor in the upcoming trial of nine activists, including media mogul Jimmy Lai. Perry's involvement sparked a widespread outcry over legal ethics in the UK.
Billionaire Jack Ma had not been seen in public since he slammed China's financial regulatory system in a speech at a Shanghai forum in October.
Questions are being raised over the international community's relations with Uganda following Museveni's win.
Thousands of Indians who were declared dead in official records have lost their rights and property.
The recent killing of a non-Kashmiri trader by militant groups has drawn focus to the tensions related to the new land and residency laws implemented by New Delhi in the disputed region.
The lockdown has been extended again, but barely tightened. Will the plan work? Not really, says Sabine Kinkartz.
Coming up at 20:30 UTC: The Day
So this is what you look like! Until now there were only computer graphics of SARS-CoV-2. Now there's a photo.
DW's Conflict Zone met top Tory lawmaker Andrew Bowie, who insisted the PM showed no "contempt for the British public."
DW takes a look at this year's festivities in the ancient city of Gondar in northern Ethiopia.
In Germany, QAnon is gaining momentum — and its most ardent followers are sticking with Donald Trump. DW investigates.
As the US presidential inauguration draws nearer, Siemens CEO Joe Kaeser assesses Joe Biden's economic plans.
An exclusive audio-only discussion app is taking off in Germany. But Clubhouse has also been called elitist.
The coronavirus pandemic has had consequences for tourism in Mallorca.
Historical distrust of vaccines could derail Pakistan's COVID-19 immunization drive.
Every year, for the Feast of the Epiphany, devout Russians take the plunge at one of Moscow's many ice holes.
A viral video of a woman convulsing in a hospital. Chemicals "in COVID-19 vaccines." And the "19-29% efficacy" argument.
